ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Hematology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,268Medicare Part D Prescriptions Filled, Including Refills
$616K Total Retail Price of All Prescriptions
858 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
OMEPRAZOLE 1,264 1,106
LOVASTATIN 935 880
SIMVASTATIN 904 847
ATENOLOL 848 798
LEVOTHYROXINE SODIUM 748 701
LISINOPRIL 618 574
FUROSEMIDE 585 514
ENALAPRIL MALEATE 567 530
METOPROLOL TARTRATE 529 483
METFORMIN HCL 529 480
HYDROCHLOROTHIAZIDE 444 398
GLIPIZIDE 441 381
GABAPENTIN 405 348
AMLODIPINE BESYLATE 389 369
NIFEDIPINE ER 354 337
TRAMADOL HCL 345 239
TERAZOSIN HCL 333 310
ZOLPIDEM TARTRATE 327 259
CARVEDILOL 327 307
ALENDRONATE SODIUM 315 298
POTASSIUM CHLORIDE 305 289
GEMFIBROZIL 292 242
WARFARIN SODIUM 291 289
TRIAMTERENE-HCTZ 285 249
FINASTERIDE 219 219
ISOSORBIDE MONONITRATE ER 207 167
GLIPIZIDE ER 202 189
KLOR-CON 10 196 185
DICLOFENAC SODIUM 195 181
PRAVASTATIN SODIUM 192 159
ALLOPURINOL 190 177
ATENOLOL-CHLORTHALIDONE 189 171
NAPROXEN 179 149
MELOXICAM 169 144
CIPROFLOXACIN HCL 165 144
PREDNISONE 157 125
ACETAMINOPHEN-CODEINE 147 132 S3
HYDROCODONE-ACETAMINOPHEN 144 117 S3
AMOX TR-POTASSIUM CLAVULANATE 127 108
TEMAZEPAM 126 114
SERTRALINE HCL 121 76
ALPRAZOLAM 121 97
FLUOXETINE HCL 120 101
CITALOPRAM HBR 116 78
VENTOLIN HFA 115 80
DONEPEZIL HCL 114 114
DIGOXIN 113 113
DOXAZOSIN MESYLATE 112 104
AMOXICILLIN 108 101
AZITHROMYCIN 107 77
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 103
FOLIC ACID 99 83
MECLIZINE HCL 97 95
LOSARTAN POTASSIUM 97 91
NITROGLYCERIN PATCH 91 60
METHYLPREDNISOLONE 89 80
TIZANIDINE HCL 89 80
HUMULIN 70-30 88 77
RANITIDINE HCL 87 79
AMLODIPINE BESYLATE-BENAZEPRIL 85 66
PANTOPRAZOLE SODIUM 83 55
GLYBURIDE 83 83 R
ADVAIR DISKUS 82 69
PAROXETINE HCL 81 61
HYDRALAZINE HCL 80 78
CLOTRIMAZOLE-BETAMETHASONE 77 56
CLOPIDOGREL 73 72
FLUTICASONE PROPIONATE 70 66
METOPROLOL SUCCINATE 69 55
IBUPROFEN 69 59
TRAZODONE HCL 68 42
METOCLOPRAMIDE HCL 66 57
TAMSULOSIN HCL 64 52
PROAIR HFA 64 46
OXYBUTYNIN CHLORIDE 64 64
NIFEDICAL XL 63 56
OXYCODONE HCL-ACETAMINOPHEN 62 18 S2
JANTOVEN 59 48
SYMBICORT 56 47
LORATADINE 56 49
NITROSTAT 56 48
CLONIDINE HCL 56 47
CEPHALEXIN 54 48
SPIRONOLACTONE 54 54
CYCLOBENZAPRINE HCL 52 25 R
KLOR-CON M20 51 47
GLYBURIDE-METFORMIN HCL 51 51 R
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.